Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Harvard Business School
Merck
McKesson
Moodys

Last Updated: January 26, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Oltipraz


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Oltipraz?

Oltipraz is an investigational drug.

There have been 5 clinical trials for Oltipraz. The most recent clinical trial was a Phase 3 trial, which was initiated on November 15th 2019.

The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Liver Diseases, and Fatty Liver. The leading clinical trial sponsors are PharmaKing, National Cancer Institute (NCI), and Northwestern University.

There are four hundred and forty-nine US patents protecting this investigational drug and four international patents.

Recent Clinical Trials for Oltipraz
TitleSponsorPhase
Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver CirrhosisPharmaKingPhase 3
Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver CirrhosisPharmaKingPhase 3
Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver DiseasePharmaKingPhase 2

See all Oltipraz clinical trials

Clinical Trial Summary for Oltipraz

Top disease conditions for Oltipraz
Top clinical trial sponsors for Oltipraz

See all Oltipraz clinical trials

US Patents for Oltipraz

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Oltipraz ⤷  Sign up for a Free Trial Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases Halozyme, Inc. (San Diego, CA) ⤷  Sign up for a Free Trial
Oltipraz ⤷  Sign up for a Free Trial Pyrazolopyrimidine compounds GLAXOSMITHKLINE LLC (Wilmington, DE) ⤷  Sign up for a Free Trial
Oltipraz ⤷  Sign up for a Free Trial Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof vTv Therapeutics LLC (High Point, NC) ⤷  Sign up for a Free Trial
Oltipraz ⤷  Sign up for a Free Trial Methods for the prevention and the treatment of rapidly progressive glomerulonephritis INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) UNIVERSITE PARIS DESCARTES (Paris, FR) ⤷  Sign up for a Free Trial
Oltipraz ⤷  Sign up for a Free Trial Six-membered C--N-bonded aryl sulphide and aryl sulphoxide derivatives as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE) ⤷  Sign up for a Free Trial
Oltipraz ⤷  Sign up for a Free Trial Bicyclic compound, production and use thereof TOBIRA THERAPEUTICS, INC. (South San Francisco, CA) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Oltipraz

Drugname Country Document Number Estimated Expiration Related US Patent
Oltipraz Austria AT448323 2023-03-05 ⤷  Sign up for a Free Trial
Oltipraz Australia AU2004218354 2023-03-05 ⤷  Sign up for a Free Trial
Oltipraz Australia AU2006216545 2023-03-05 ⤷  Sign up for a Free Trial
Oltipraz Australia AU2009245838 2023-03-05 ⤷  Sign up for a Free Trial
Oltipraz Australia AU2013202475 2023-03-05 ⤷  Sign up for a Free Trial
Oltipraz Brazil BRPI0408116 2023-03-05 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Harvard Business School
Merck
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.